202 related articles for article (PubMed ID: 34505522)
1. Introduction to DOK2 and its potential role in cancer.
Sun P; Li R; Meng Y; Xi S; Wang Q; Yang X; Peng X; Cai J
Physiol Res; 2021 Nov; 70(5):671-685. PubMed ID: 34505522
[TBL] [Abstract][Full Text] [Related]
2. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
Downer EJ; Johnston DG; Lynch MA
Mol Cell Neurosci; 2013 Sep; 56():148-58. PubMed ID: 23659921
[TBL] [Abstract][Full Text] [Related]
3. DOK2 inhibits EGFR-mutated lung adenocarcinoma.
Berger AH; Chen M; Morotti A; Janas JA; Niki M; Bronson RT; Taylor BS; Ladanyi M; Van Aelst L; Politi K; Varmus HE; Pandolfi PP
PLoS One; 2013; 8(11):e79526. PubMed ID: 24255704
[TBL] [Abstract][Full Text] [Related]
4. Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.
Mihrshahi R; Brown MH
J Immunol; 2010 Dec; 185(12):7216-22. PubMed ID: 21078907
[TBL] [Abstract][Full Text] [Related]
5. Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells.
Mihrshahi R; Barclay AN; Brown MH
J Immunol; 2009 Oct; 183(8):4879-86. PubMed ID: 19786546
[TBL] [Abstract][Full Text] [Related]
6. Identification of DOK genes as lung tumor suppressors.
Berger AH; Niki M; Morotti A; Taylor BS; Socci ND; Viale A; Brennan C; Szoke J; Motoi N; Rothman PB; Teruya-Feldstein J; Gerald WL; Ladanyi M; Pandolfi PP
Nat Genet; 2010 Mar; 42(3):216-23. PubMed ID: 20139980
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid induces p62DOK1 and p56DOK2 expression which enhances induced differentiation and G0 arrest of HL-60 leukemia cells.
Lamkin TJ; Chin V; Yen A
Am J Hematol; 2006 Aug; 81(8):603-15. PubMed ID: 16823827
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of Dok-R to the EGF receptor through its PTB domain is required for attenuation of Erk MAP kinase activation.
Jones N; Dumont DJ
Curr Biol; 1999 Sep; 9(18):1057-60. PubMed ID: 10508618
[TBL] [Abstract][Full Text] [Related]
9. Dok1 and Dok2 Proteins Regulate Cell Cycle in Hematopoietic Stem and Progenitor Cells.
Coppin E; De Grandis M; Pandolfi PP; Arcangeli ML; Aurrand-Lions M; Nunès JA
J Immunol; 2016 May; 196(10):4110-21. PubMed ID: 27183638
[TBL] [Abstract][Full Text] [Related]
10. Dok1 and Dok2 proteins regulate natural killer cell development and function.
Celis-Gutierrez J; Boyron M; Walzer T; Pandolfi PP; Jonjić S; Olive D; Dalod M; Vivier E; Nunès JA
EMBO J; 2014 Sep; 33(17):1928-40. PubMed ID: 24963146
[TBL] [Abstract][Full Text] [Related]
11. DOK2 as a marker of poor prognosis of patients with gastric adenocarcinoma after curative resection.
Miyagaki H; Yamasaki M; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y
Ann Surg Oncol; 2012 May; 19(5):1560-7. PubMed ID: 22130622
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the tumor suppressor C-terminal Src kinase (Csk)-binding protein (Cbp)/PAG1 is mediated by epigenetic histone modifications via the mitogen-activated protein kinase (MAPK)/phosphatidylinositol 3-kinase (PI3K) pathway.
Suzuki K; Oneyama C; Kimura H; Tajima S; Okada M
J Biol Chem; 2011 May; 286(18):15698-706. PubMed ID: 21388951
[TBL] [Abstract][Full Text] [Related]
13. Effects of expressing human T-cell leukemia virus type 1 (HTLV-I) oncoprotein Tax on DOK1, DOK2 and DOK3 gene expression in mice.
Ohsugi T
J Vet Med Sci; 2017 May; 79(5):935-938. PubMed ID: 28302940
[TBL] [Abstract][Full Text] [Related]
14. Dok2 mediates the CD200Fc attenuation of Aβ-induced changes in glia.
Lyons A; Downer EJ; Costello DA; Murphy N; Lynch MA
J Neuroinflammation; 2012 May; 9():107. PubMed ID: 22642833
[TBL] [Abstract][Full Text] [Related]
15. Expression of DOK1, 2, and 3 genes in HTLV-1-infected T cells.
Ohsugi T; Wakamiya M; Morikawa S; Fujita M
Acta Virol; 2016 Jun; 60(2):211-3. PubMed ID: 27265473
[TBL] [Abstract][Full Text] [Related]
16. Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis.
Lum E; Vigliotti M; Banerjee N; Cutter N; Wrzeszczynski KO; Khan S; Kamalakaran S; Levine DA; Dimitrova N; Lucito R
Gynecol Oncol; 2013 Aug; 130(2):369-76. PubMed ID: 23684582
[TBL] [Abstract][Full Text] [Related]
17. Mutational and expressional analysis of a haploinsufficient tumor suppressor gene DOK2 in gastric and colorectal cancers.
An CH; Kim MS; Yoo NJ; Lee SH
APMIS; 2011 Aug; 119(8):562-4. PubMed ID: 21749457
[No Abstract] [Full Text] [Related]
18. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling.
Shinohara H; Inoue A; Toyama-Sorimachi N; Nagai Y; Yasuda T; Suzuki H; Horai R; Iwakura Y; Yamamoto T; Karasuyama H; Miyake K; Yamanashi Y
J Exp Med; 2005 Feb; 201(3):333-9. PubMed ID: 15699069
[TBL] [Abstract][Full Text] [Related]
19. Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases.
Honma M; Higuchi O; Shirakata M; Yasuda T; Shibuya H; Iemura S; Natsume T; Yamanashi Y
Genes Cells; 2006 Feb; 11(2):143-51. PubMed ID: 16436051
[TBL] [Abstract][Full Text] [Related]
20. Region-Specific Dok2 Overexpression Associates with Poor Prognosis in Human Astrocytoma.
Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
Mol Neurobiol; 2018 Jan; 55(1):402-408. PubMed ID: 27975172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
